Neuro-Oncology Biomarkers

Treatment of mind tumors is progressively educated by biomarkers. One use is to properly bunch tumors with comparative hereditary/genomic attributes and to plan preliminaries independently for the individual gatherings. The biomarker's utilization is to foresee patient reaction so the best treatment can be chosen for patients dependent on their tumor attributes. Preliminary plans that select unselected patients are inadequately appropriate for distinguishing medicines successful just in subsets of patients given the generally little quantities of patients accessible for preliminaries.

    Related Conference of Neuro-Oncology Biomarkers

    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    November 24-25, 2026

    38th World Conference on Neurology

    Rome, Italy
    December 16-17, 2026

    12th International Conference on Brain Injury & Neuro Surgeons

    Amsterdam, Netherlands
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France
    December 28-29, 2026

    39th European Neurology Congress

    Amsterdam, Netherlands
    December 28-29, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    March 22-23, 2027

    8th International Conference on Neurologists

    Singapore City, Singapore
    March 24-25, 2027

    38th Conference on Clinical Neuroscience and Neurogenetics

    Geneva, Switzerland

    Neuro-Oncology Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in